Childhood Cancer and the Risk of ESKD

被引:6
作者
Calderon-Margalit, Ronit [1 ]
Pleniceanu, Oren [2 ,3 ,4 ,5 ]
Tzur, Dorit [3 ,4 ]
Stern-Zimmer, Michal [6 ,7 ]
Afek, Arnon [2 ,8 ]
Erlich, Tomer [2 ,3 ,4 ,9 ]
Verhovsky, Guy [3 ,4 ,10 ,11 ]
Keinan-Boker, Lital [12 ,13 ]
Skorecki, Karl [14 ,15 ,16 ]
Twig, Gilad [3 ,4 ,17 ,18 ,19 ]
Vivante, Asaf [2 ,6 ,7 ,17 ]
机构
[1] Hadassah Hebrew Univ, Braun Sch Publ Hlth, POB 12272, IL-9112102 Jerusalem, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Hebrew Univ Jerusalem, Dept Mil Med, Jerusalem, Israel
[4] Israel Def Forces Med Corps, Ramat Gan, Israel
[5] Sheba Med Ctr, Kidney Res Inst, Tel Hashomer, Israel
[6] Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Dept Pediat B, Tel Hashomer, Israel
[7] Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Pediat Nephrol Unit, Tel Hashomer, Israel
[8] Chaim Sheba Med Ctr, Cent Management, Tel Hashomer, Israel
[9] Sheba Med Ctr, Dept Urol, Ramat Gan, Israel
[10] Shamir Assaf Harofeh Med Ctr, Dept Urol, Zerifin, Israel
[11] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[12] Minist Hlth, Israel Ctr Dis Control, Tel Hashomer, Israel
[13] Univ Haifa, Sch Publ Hlth, Haifa, Israel
[14] Technion Israel Inst Technol, Rambam Hlth Care Campus, Dept Nephrol, Haifa, Israel
[15] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
[16] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel
[17] Sheba Med Ctr, Talpiot Med Leadership Program, Tel Hashomer, Israel
[18] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel
[19] Sheba Med Ctr, Inst Endocrinol, Tel Hashomer, Israel
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 02期
基金
以色列科学基金会;
关键词
ESKD; cancer; pediatric nephrology; ADULT SURVIVORS; TIME TRENDS; NEPHROTOXICITY; CHILDREN; KIDNEY;
D O I
10.1681/ASN.2020071002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Increasing cancer incidence among children alongside improved treatments has resulted in a growing number of pediatric cancer survivors. Despite childhood cancer survivors' exposure to various factors that compromise kidney function, few studies have investigated the association between childhood cancer and future kidney disease. Methods To assess the risk of ESKD among childhood cancer survivors, we conducted a nationwide, population-based, retrospective cohort study that encompassed all Israeli adolescents evaluated for mandatory military service from 1967 to 1997. After obtaining detailed histories, we divided the cohort into three groups: participants without a history of tumors, those with a history of a benign tumor (nonmalignant tumor with functional impairment), and those with a history of malignancy (excluding kidney cancer). This database was linked to the Israeli ESKD registry to identify incident ESKD cases. We used Cox proportional hazards models to estimate the hazard ratio (HR) of ESKD. Results Of the 1,468,600 participants in the cohort, 1,444,345 had no history of tumors, 23,282 had a history of a benign tumor, and 973 had a history of malignancy. During a mean follow-up of 30.3 years, 2416 (0.2%) participants without a history of tumors developed ESKD. Although a history of benign tumors was not associated with an increased ESKD risk, participants with a history of malignancy exhibited a substantially elevated risk for ESKD compared with participants lacking a history of tumors, after controlling for age, sex, enrollment period, and paternal origin (adjusted HR, 3.2; 95% confidence interval, 1.3 to 7.7). Conclusions Childhood cancer is associated with an increased risk for ESKD, suggesting the need for tighter and longer nephrological follow-up. Significance Statement The number of pediatric cancer survivors has steadily increased in recent decades because of higher incidence rates of cancer and improved treatments. Although children with cancer are exposed to various factors that might compromise kidney function, whether childhood cancer is associated with an increased risk of ESKD at adulthood is unknown. In this population-based, retrospective cohort study in Israel comprising 1,468,600 participants, the authors found that individuals with a history of childhood cancer had a risk of ESKD during a follow-up period of 30 years that was substantially elevated compared with that of individuals who were not childhood cancer survivors. These findings demonstrate a link between experiencing cancer during childhood and adverse renal outcome during adulthood, suggesting the need for closer and longer nephrological follow-up of survivors of childhood cancer.
引用
收藏
页码:495 / 501
页数:7
相关论文
共 27 条
[1]   COX REGRESSION-MODEL FOR COUNTING-PROCESSES - A LARGE SAMPLE STUDY [J].
ANDERSEN, PK ;
GILL, RD .
ANNALS OF STATISTICS, 1982, 10 (04) :1100-1120
[2]   PROGNOSIS OF CHILDREN WITH SOLITARY KIDNEY AFTER UNILATERAL NEPHRECTOMY [J].
ARGUESO, LR ;
RITCHEY, ML ;
BOYLE, ET ;
MILLINER, DS ;
BERGSTRALH, EJ ;
KRAMER, SA .
JOURNAL OF UROLOGY, 1992, 148 (02) :747-751
[3]   Long-term risk of renal and urinary tract diseases in childhood cancer survivors: A population-based cohort study [J].
Bonnesen, Trine Gade ;
Winther, Jeanette F. ;
Asdahl, Peter H. ;
Licht, Sofie de Fine ;
Gudmundsdottir, Thorgerdur ;
Holmqvist, Anna Saellfors ;
Madanat-Harjuoja, Laura-Maria ;
Tryggvadottir, Laufey ;
Wesenberg, Finn ;
Birn, Henrik ;
Olsen, Jorgen H. ;
Hasle, Henrik .
EUROPEAN JOURNAL OF CANCER, 2016, 64 :52-61
[4]   Dialysis in Israel, 1989-2005 - time trends and international comparisons [J].
Calderon-Margalit, Ronit ;
Gordon, Ethel-Sherry ;
Hoshen, Moshe ;
Kark, Jeremy D. ;
Rotem, Anat ;
Haklai, Ziona .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (02) :659-664
[5]   Long-Term Nephrotoxicity in Adult Survivors of Childhood Cancer [J].
Dekkers, Ilona A. ;
Blijdorp, Karin ;
Cransberg, Karlien ;
Pluijm, Saskia M. ;
Pieters, Rob ;
Neggers, Sebastian J. ;
van den Heuvel-Eibrink, Marry M. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (06) :922-929
[6]   Etiology and outcome of acute kidney injury in children [J].
Duzova, Ali ;
Bakkaloglu, Aysin ;
Kalyoncu, Mukaddes ;
Poyrazoglu, Hakan ;
Delibas, Ali ;
Ozkaya, Ozan ;
Peru, Harun ;
Alpay, Harika ;
Soylemezoglu, Oguz ;
Gur-Guven, Ayfer ;
Bak, Mustafa ;
Bircan, Zelal ;
Cengiz, Nurcan ;
Akil, Ipek ;
Ozcakar, Birsin ;
Uncu, Nermin ;
Karabay-Bayazit, Aysun ;
Sonmez, Ferah .
PEDIATRIC NEPHROLOGY, 2010, 25 (08) :1453-1461
[7]   Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities [J].
Estrada, Chelsea C. ;
Maldonado, Alejandro ;
Mallipattu, Sandeep K. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (02) :187-200
[8]  
Glezerman I, 2009, CLIN NEPHROL, V71, P130
[9]   Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events [J].
Herrmann, Sandra M. ;
Perazella, Mark A. .
KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08) :1139-1148
[10]   Preventing and Managing Toxicities of High-Dose Methotrexate [J].
Howard, Scott C. ;
McCormick, John ;
Pui, Ching-Hon ;
Buddington, Randall K. ;
Harvey, R. Donald .
ONCOLOGIST, 2016, 21 (12) :1471-1482